Welcome to LookChem.com Sign In|Join Free

CAS

  • or

18977-33-8

Post Buying Request

18977-33-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18977-33-8 Usage

General Description

2,6-Bis-(3,4-Dimethoxyphenylmethylene)-Cyclohexanone is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. Its chemical structure consists of a cyclohexanone ring with two 3,4-dimethoxyphenylmethylene groups attached at the 2 and 6 positions. 2,6-Bis-(3,4-Dimethoxyphenylmethylene)-Cyclohexanone has been studied for its potential use in the development of new drugs, particularly in the area of anti-inflammatory and analgesic medications. Additionally, it has shown promising results in the inhibition of specific enzymes involved in the progression of certain diseases. Overall, 2,6-Bis-(3,4-Dimethoxyphenylmethylene)-Cyclohexanone is a versatile chemical compound with potential applications in various fields of science and medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 18977-33-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,9,7 and 7 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 18977-33:
(7*1)+(6*8)+(5*9)+(4*7)+(3*7)+(2*3)+(1*3)=158
158 % 10 = 8
So 18977-33-8 is a valid CAS Registry Number.
InChI:InChI=1/C24H26O5/c1-26-20-10-8-16(14-22(20)28-3)12-18-6-5-7-19(24(18)25)13-17-9-11-21(27-2)23(15-17)29-4/h8-15H,5-7H2,1-4H3/b18-12+,19-13+

18977-33-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-Bis-(3,4-dimethoxyphenylmethylene)cyclohexanone

1.2 Other means of identification

Product number -
Other names 2,6-BIS(3,4-DIMETHOXYBENZYLIDENE)-1-CYCLOHEXANONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18977-33-8 SDS

18977-33-8Relevant articles and documents

Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro

Leong, Sze Wei,Chia, Suet Lin,Abas, Faridah,Yusoff, Khatijah

, p. 716 - 728 (2018)

In the present study, a series of forty-five asymmetrical meta-methoxylated diarylpentanoids have been synthesized, characterized and evaluated for their in-vitro anti-cancer potential. Among the forty-five analogs, three compounds (20, 33 and 42) have been identified as lead compounds due to their excellent inhibition against five human cancer cell lines including SW620, A549, EJ28, HT1080 and MCF-7. Structure-activity relationship study on cytotoxicity of tested compounds suggested that the presence of meta-oxygenated phenyl ring played a critical role in enhancing their cytotoxic effects. Compounds 33 and 42 in particular, exhibited strongest cytotoxicity against tested cell lines with the IC50 values ranging from 1.1 to 4.3 μM. Subsequent colony formation assay on SW620 cell line showed that both compounds 33 and 42 possessed strong anti-proliferative activity. In addition, flow cytometry based experiments revealed that these compounds could trigger intracellular ROS production thus inducing G2/M-phase cell arrest and apoptosis. All these results suggested that poly meta-oxygenated diarylpentnoid is a promising scaffold which deserved further modification and investigation in the development of natural product-based anti-cancer drug.

Mechanistic investigations on substituted benzene sulphonamides as apoptosis inducing anticancer agents

Mettu, Akhila,Naikal James Prameela, Subhashini,Talla, Venu,Thumma, Soujanya

, (2020/01/28)

In an approach to develop potent cytotoxic compounds with targeted action, a systematic methodology was employed to design and initially synthesize parent compounds A1, A8, A13 and A14 followed by synthesis of further analogs of A1 (A2-A7) and A8 (A9-A12)

Symmetrical and unsymmetrical substituted 2,5-diarylidene cyclohexanones as anti-parasitic compounds

Din, Zia Ud,Trapp, Marilia Almeida,Soman de Medeiros, Lívia,Lazarin-Bidóia, Danielle,Garcia, Francielle Pelegrin,Peron, Francieli,Nakamura, Celso Vataru,Rodríguez, Ihosvany Camps,Wadood, Abdul,Rodrigues-Filho, Edson

, p. 596 - 608 (2018/06/20)

Symmetrical and unsymmetrical bis-aryl-α,β-unsaturated ketones were synthesized in moderate to excellent yield by treating cyclohexanone with various aldehydes. Dimethylammonium dimethylcarbamate (DIMCARB) was used as both catalyst and reaction medium for the synthesis of monoarylidenes cycloadduct intermediates, which was further used to produce diarylidene cyclohexanones. All the 34 compounds synthesized were evaluated for their anti-proliferative activity, particularly against promastigote of Leishmania amazonensis, epimastigoteand trypomastigoteof Trypanosoma cruzi. Eighteen compounds displayed anti-leishmanial activity against promastigotes of L. amazonensis with IC50 values ranging from 2.8 to 10 μM. In addition, two compounds exhibited significant antitrypanosomal activity against epimastigotes of T. cruzi with IC50 values of 5.2 ± 0.8 and 3.0 ± 0.0 μM, while five compounds exhibited activity from 15.0 ± 1.4 to 30.2 ± 1.8 μM against trypomastigote of T. cruzi. Moreover, all compounds were more selective against the parasites than the epithelial cells. The unsymmetrical compounds 16, 28, 30 and 33 can be considered as favorable anti-parasitic lead molecule having IC50 and EC50 values in the low-micromolar range, better than the reference drug benznidazole, and low cytotoxicity against Vero cells. The potent compounds were screened in silico against 17 enzymes of T. cruzi and best scoring were found against Dihydroorotate Dehydrogenase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 18977-33-8